Ribavirin Sodium Chloride Injection

This product can inhibit the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. This product may also have an immune effect on respiratory syncytial virus and a neutralizing antibody effect.

The main ingredient of this product is ribavirin, whose chemical name is 1-beta;-D-ribofuranosyl-1,2,4-triazole-3-amide.

For viral upper respiratory tract infections.

Intravenous drip: Adults, 0.5 g each time, twice a day, for 5 consecutive days, or as directed by a doctor.

Some patients may experience digestive tract reactions such as nausea, vomiting, and loss of appetite.

1. Those who are allergic to this product are prohibited from using it; 2. Pregnant and lactating women are prohibited from using this product.

Precautions during pregnancy and lactation: Pregnant and lactating women are prohibited from using.

This product has an antagonistic effect when used together with zidovudine, because this product can inhibit the conversion of zidovudine into active zidovudine phosphate.

Keep in dark, airtight and cool place.

250ml: Ribavirin 0.5g, Sodium chloride 2.125g

YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd.

• Founded in:

  2001-01-16

• Address:

  No. 9 Xianlin Avenue, Qixia District, Nanjing

• Tax NO.:

  91320192726063334T

• Registered Funds:

  50 million yuan

• Website:

  Log in to view

• Email:

  Log in to view